Selena Larkin PhD MBA
Chief Commercial Officer, RareCyte Inc., Board Member, Investor & Advisory Board Member
Technology:
Pharmaceutical Drug Discovery and Development, Clinical Diagnostics, Liquid Biopsy, Spatial Biology, Protein Biomarkers, Oncology, Biotechnology, Cell and Gene Therapy
Operating:
Leadership, Corporate and Business Strategy, Go-to-Market, Branding, Commercialization, Global Expansion, Product Launch, Portfolio Lifecycle Management, Corporate Development, Corporate Innovation, Partnering, Acquisition and Integration, Supply Chain Management, Business Transformation and Optimization, Fundraising, Culture Building, Change Management, Diversity, Equity and Inclusion,
Scale:
Early stage startup, VC Funded, Public Companies ($32B revenue)
Design by: